You are here

News

Advancing European healthcare in Strasbourg

10 Oct 2025
All committees
Healthcare

From Tuesday, 7 to Wednesday, 8 October, AmCham EU travelled to the European Parliament in Strasbourg, France to engage with MEPs on the future of EU health policy. In meetings with over a dozen policymakers, members underscored the importance of a competitive, innovation-driven life sciences sector that ensures timely patient access to medicines and technologies. The discussions also covered the General Pharmaceutical Legislation, the Medical Devices Regulation, the Critical Medicines Act and the upcoming Biotech Act. The delegation called for evidence-based, proportionate policies that promote regulatory coherence and support Europe’s global leadership in health innovation. 

Strengthening Europe’s cyber talent pipeline

2 Oct 2025
All committees

The cybersecurity industry is evolving rapidly, driven by new systemic risks with financial and societal implications. Furthermore, a shortage of trained technology professionals is impeding progress. To address this skills gap, the Kyndryl Foundation has awarded two rounds of grants to nonprofit organisations across Europe that support cybersecurity training and job placement. This year, five European grantees are running programmes that empower women, youth and underserved communities with essential technology skills. These initiatives are expected to reach more than 55,000 Europeans over the next two years. Learn how Kyndryl is strengthening Europe’s cyber talent pipeline on Invested in Europe

Examining where transatlantic trade goes from here with POLITICO

2 Oct 2025
All committees

At the POLITICO Competitive Europe Summit, Malte Lohan, CEO, AmCham EU reiterated the need for swift implementation of the EU-US Framework Agreement and renewed its call for greater simplification of EU rules. Mr Lohan expressed cautious support for the deal, noting its role in avoiding damaging escalation and restoring a degree of predictability. He also underscored the importance of reducing regulatory burdens, highlighting simplification as a strategic priority for competitiveness. With the priority now on timely tariff reductions, regulatory cooperation and simplification, find out how our members see the deal evolving